These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21700241)

  • 41. Frequent malaria illness episodes in two Malawian patients on antiretroviral therapy soon after stopping cotrimoxazole preventive therapy.
    Nyangulu WJ; Mwinjiwa E; Divala TH; Mungwira RG; Nyirenda O; Kanjala M; Mbambo G; Mallewa J; Taylor TE; Laurens MB; Laufer MK; van Oosterhout JJ
    Malawi Med J; 2017 Mar; 29(1):57-60. PubMed ID: 28567199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
    Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
    Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.
    Chico RM; Dellicour S; Roman E; Mangiaterra V; Coleman J; Menendez C; Majeres-Lugand M; Webster J; Hill J
    Malar J; 2015 May; 14():207. PubMed ID: 25986063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Malaria during pregnancy: consequences and interventional perspectives].
    Cot M; Deloron P
    Med Trop (Mars); 2003; 63(4-5):369-80. PubMed ID: 14763291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy.
    Aminake MN; Mahajan A; Kumar V; Hans R; Wiesner L; Taylor D; de Kock C; Grobler A; Smith PJ; Kirschner M; Rethwilm A; Pradel G; Chibale K
    Bioorg Med Chem; 2012 Sep; 20(17):5277-89. PubMed ID: 22858300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.
    Mangesho PE; Reynolds J; Lemnge M; Vestergaard LS; Chandler CI
    Malar J; 2014 Dec; 13():491. PubMed ID: 25495956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.
    González R; Rupérez M; Sevene E; Vala A; Maculuve S; Bulo H; Nhacolo A; Mayor A; Aponte JJ; Macete E; Menendez C
    PLoS One; 2017; 12(6):e0178134. PubMed ID: 28575010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes.
    Nathoo S; Serghides L; Kain KC
    Lancet; 2003 Sep; 362(9389):1039-41. PubMed ID: 14522535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malaria Surveillance - United States, 2014.
    Mace KE; Arguin PM
    MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
    Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
    Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials.
    Kent DM; Mwamburi DM; Bennish ML; Kupelnick B; Ioannidis JP
    JAMA; 2004 Jul; 292(2):237-42. PubMed ID: 15249573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-malaria interactions in North-East India: A prospective cohort study.
    Mohapatra PK; Pachuau E; Kumar C; Borkakoty B; Zomawia E; Singh A; Walia K; Arora R; Mahanta J; Subbarao SK
    Indian J Med Res; 2017 Mar; 145(3):387-394. PubMed ID: 28749403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.
    Davis NL; Barnett EJ; Miller WC; Dow A; Chasela CS; Hudgens MG; Kayira D; Tegha G; Ellington SR; Kourtis AP; van der Horst C; Jamieson DJ; Juliano JJ
    Clin Infect Dis; 2015 Aug; 61(3):368-74. PubMed ID: 25900173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 18 March 1999. Fresh from the field: some controversies in tropical medicine and hygiene. HIV and malaria, do they interact?
    French N; Gilks CF
    Trans R Soc Trop Med Hyg; 2000; 94(3):233-7. PubMed ID: 10974985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malaria and hiv in adults: when the parasite runs into the virus.
    Focà E; Odolini S; Brianese N; Carosi G
    Mediterr J Hematol Infect Dis; 2012; 4(1):e2012032. PubMed ID: 22708047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A brief review on features of falciparum malaria during pregnancy.
    Manirakiza A; Serdouma E; Ngbalé RN; Moussa S; Gondjé S; Degana RM; Bata GGB; Moyen JM; Delmont J; Grésenguet G; Sepou A
    J Public Health Afr; 2017 Dec; 8(2):668. PubMed ID: 29456824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The potential for interactions between antimalarial and antiretroviral drugs.
    Khoo S; Back D; Winstanley P
    AIDS; 2005 Jul; 19(10):995-1005. PubMed ID: 15958830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.